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Abstract
Background: A considerable evidence suggests that maternal inflammation
dysregulation may play as a risk factor for both maternal and neonatal outcomes.
Objective: The study’s objectives were designed to evaluate the correlation between
serum C-reactive protein (CRP) levels, as an inflammation factor, preterm delivery, and
small for gestational age (SGA) births.
Materials and Methods: This prospective cohort study was conducted on 120
singleton pregnant women with gestational age less than 20 wk. Maternal CRP serum
concentration was measured before 20 wk gestation. Patients were followed-up until
the delivery and final outcomes of pregnancy were recorded in terms of preterm
delivery and SGA births.
Results: Serum CRP levels in participants with normal fetuses and SGA births were
4.09 ± 1.35 mg/l and 6.04 ± 3.29 mg/l, respectively (p = 0.19), while in cases of
preterm delivery, it was 9.63 ± 5.78 mg/l (p < 0.001). By using receiver operating
characteristic (ROC) curve, serum CRP levels (cut-off point 5.27 mg/l, area 0.836) had
acceptable diagnostic accuracy value in distinguishing preterm delivery (sensitivity
(75%), specificity (86.1%), positive predictive value (37.5%), negative predictive value
(96.87%), accuracy (85%)) and serum CRP levels (cut-off point 6.67 mg/l, area 0.673) in
distinguishing SGA births (sensitivity (50%), specificity (91.2%), positive predictive value
(23.07%), and negative predictive value (97.19%), and accuracy (89.16 %)).
Conclusion: Higher maternal serum CRP levels measured early in pregnancy may
associate with higher risk of preterm delivery and SGA.
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1. Introduction
Preterm delivery is a significant health problem,
leading cause of long-term neonatal illness, and
is accompanied by behavioral consequences and
death in about 75% of survivors (1). Similarly, small
for gestational age (SGA) infants are complicated
by long-term neurodevelopmental and behavioral
problems later in life (2). Despite the severity
of these complications, their mechanisms and
causes are poorly understood. Hence, there
are limitations in the prediction and prevention of
pretermdelivery and SGA.Most risk factors for SGA
focus on abnormalities of the placental–maternal
edge. An accumulating body of evidence suggests
that these abnormalities mostly originate at early
pregnancy and affect implantation and placental
development (3, 4). During these processes,
immune regulatory changes occur to prevent
maternal allogenic response toward the fetus. Few
studies have assessed these immune changes
due to the lack of maternal blood samples prior
to routine prenatal visits. Moreover, Georgiou
and colleagues showed that SGA is associated
with maternal cytokines abnormalities (4). On the
other hand, considerable evidence proposed
two important pathways including bacterial
infection of the chorioamnion and also intrauterine
infections as the significant contributors to preterm
delivery (5). These pathways are associated with
proinflammatory responses leading to systemic
maternal inflammation cytokines production
(6). Some studies reported infections as leading
causes of preterm deliveries of 30–50% of affected
women (7, 8).
C-reactive protein (CRP) is a stable, nonspecific,
and sensitive serum marker of systematic
inflammation secreted by hepatocytes in response
to infection (9). Elevated CRP levels in the
peripheral blood circulation are associated with
intrauterine infection and amnionitis (10). The
increased risk of preterm deliveries with high
CRP concentration at early pregnancy is proved
by some investigators (11, 12) but not all (13). In
addition, there are few studies investigating the
association between immune regulatory changes
including CRP levels with SGA (2, 4). The early
assessment of maternal serum CRP may contribute
to early detection of SGA births and to the timely
adminstration of preventive procedures. However,
a considerable evidence suggests that maternal
inflammation dysregulation may play a role for both
maternal and neonatal outcomes (2, 3, 14, 15). The
paucity of studies has explored the association
between maternal serum concentrations of CRP
at early pregnancy and preterm delivery and/or
neonatal outcomes (2).
The aim of this study was to evaluate the
correlation between serum level CRP and maternal
and neonatal adverse outcomes including preterm
delivery and SGA.
2. Materials and Methods
2.1. Study design and target group
This prospective cohort study was conducted
on 120 pregnant women who delivered at the
Obstetrics and Gynecology Department of
a tertiary-care hospital affiliated with Ahvaz
Jundishapur University of Medical Sciences in
the south-west of Iran from January 2016 to
March 2017. Pregnant women with a positive
chemical test before 20 wk gestation attending
for their first routine visit at the prenatal care clinic
were recruited in the study. In the first visit, the
participants provided the demographic, maternal
characteristics, medical history, and maternal urine
and blood samples. The maternal age, body mass
index (BMI), gravidity were collected from the
medical record. The participants were followed-up
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until delivery to observe the outcomes of the study
including preterm and SGA births.
The inclusion criteria for the study consisted of
women aged 18-35 yr old, singleton fetus, recalling
the exact date of the last menstrual period, GA
≤ 20 wk (5-20 wk of gestation) in the first visit,
regular menstrual period, BMI ranging 18-30 kg/m2,
and a satisfaction to participate in the study.
The exclusion criteria were multiple pregnancies,
poor obstetric history, history of preterm labor,
history of SGA, failure to recall the exact date
of the last menstrual period, patients undergoing
hormone therapy, receiving statins, fibrates, and
niacin drugs, history of consuming alcohol, drug
abuse, medical system disorders such asmetabolic
syndrome, cardiovascular disorders, hypertension,
diabetes (type 1 or 2), autoimmune disorders,
inflammation disorders, urinary tract infection,
kidney and liver diseases, uterine or cervical
abnormality, obese patients with a BMI above 30
kg/m2, any other maternal or fetal complications.
The mean GA at first visit was 16 wk and the
range: 5–20wk. The GAwas assigned on the basis
of first trimester sonographic findings in which the
crown-rump length (CRL) was measured.
The maternal non-fasting blood samples were
gathered at the first visit within 10 ml vacutainer
tubes at 5–20 gestational wk, and CRP levels
were tested along with routine tests. Serum
CRP concentrations were determined by high
sensitivity enzyme-linked immunosorbent assay
(ELISA) (R & D Systems, Minneapolis, MN). The
interassay coefficient of variation and detection
limit (sensitivity) for CRP were 6.28% and 1ng/ml,
respectively.
2.2. Ethical consideration
The study was approved by the
Ethical Committee of Ahvaz Jundishapur
University of Medical Sciences (Ethical code:
IR.AJUMS.REC.1395.547). All participants gave
informed consent.
2.3. Statistical analysis
Datawere analyzed using SPSS software version
18.0 for windows (Statistical Package for the Social
Sciences, SPSS, Chicago, IL, USA). The mean
of serum CRP levels was compared between
subgroups of variables including maternal age,
BMI, gravidity, birth weight, time of delivery, and
SGA and non-SGA infants. The means of serum
CRP levels between variables were compared
using either independent samples t test for
two groups or one-way ANOVA for more than
two groups. ROC curve analysis was utilized to
determine the best cut-off point of serum CRP
levels for preterm delivery as well as SGA births.
The odd ratios and accuracy were calculated to
examine the risk of preterm delivery and SGA
birth. P-value < 0.05 was considered statistically
significant.
3. Results
As shown in Table I, the ranges of participants’
age, GA at study assignment, and GA at
delivery were 19-35 yr, 5-20 wk, and 31.2-41
wk, respectively. The mean of serum CRP levels
of patients was 4.6 ± 2.7 mg/l and the average
of infants’ birth weight was 3241.7 ± 740.0 gr. Of
the 120 pregnant women, the rates of cases with
normal fetus, preterm labor and SGA births were
89.16%, 10% and 5%, respectively.
The mean concentration of serum CRP levels
was lower but not significant in women with normal
fetuses when compared with SGA births’ group (p =
0.19). The mean of CRP levels in preterm deliveries
was much higher than the term deliveries (p <
0.001) (Table II). Furthermore, the mean of CRP
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levels significantly increased while the birth weight
decreased. We did not find significant differences
in the CRP levels betweenmaternal age subgroups
(p = 0.14), maternal BMI subgroups (p = 0.40), and
gravidity subgroups (p = 0.9) (Table II).
Notably, maternal serum CRP levels exhibited
a sensitivity of 75%, the specificity of 86.1%, the
accuracy of 85%, and the area under the curve of
0.836 (0.693–0.980) at a cut−off value = 5.27 mg/l
as a preterm delivery predictive marker (p < 0.001).
The use of amaternal serumCRP level cut-off value
of 6.67 mg/l allowed distinguishing SGA and non-
SGA births with a sensitivity of 50%, a specificity
of 91.2%, an accuracy of 89.2%, area under the
curve of 0.673 (0.441–0.905) (p = 0.15) (Tables III
and IV).
One-unit increase in serum CRP levels elevated
the risk of preterm delivery by 2.3-fold (odds ratio
= 2.26, 95% CI: 1.28–3.99, p = 0.005). The CRP
level ≥ 5.27 mg/l was significantly associated with
a dramatically higher rate of preterm delivery (OR
= 18.6, 95% CI: 4.51–76.6, p < 0.0001). Indeed,
a one-unit increase in serum CRP levels was not
associated with the risk of SGA birth delivery (OR =
1.13, 95%CI: 0.93–1.34, p = 0.20). The CRP level of≥
6.67 mg/l was significantly associated with a higher
rate of SGA births (OR = 10.4, 95% CI: 1.88–58.4, p
= 0.008) (Table V).
Table I. Demographic and maternal characteristics of the study population (n = 120)
Mean ± SD Min–Max
Age (yr) 26.5 ± 4.4 19–35
Gestational age (wk) 16.1 ± 4.3 5–20
BMI (kg/m2) 23.9 ± 3.3 15.6–30
Gravida (median) 2 1–5
Birth weight (gr) 3241.7 ± 740.0 1500–4600
C-reactive (mg/l) 4.6 ± 2.7 1.77–20.20
Gestational age at delivery (wk) 37.2 ± 1.7 31.2–41
Yr: Year; wk: Week; BMI: Body mass index; gr: Gram; mg/l (milligram per liter)
Table II. Early pregnancy maternal serum CRP (mg/l) levels according to maternal characteristics (n = 120)
N Mean ± SD P-value
< 25 44 4.14 ± 1.49
25–30 50 5.2 ± 3.8Maternal age
> 30 26 4.27 ± 1.59
0.14𝑎
< 20 18 5.4 ± 4.4
20–25 57 4.6 ± 2.6BMI
> 25 45 4.4 ± 2.0
0.40𝑎
1 30 4.8 ± 2.6
2 61 4.5 ± 2.5Gravidity
≥ 3 29 4.7 ± 3.5
0.90𝑎
< 2000 13 9.3 ± 5.6
2000–3500 66 3.9 ± 1.4Birth weight
> 3500 41 4.2 ± 1.2
< 0.001𝑎
No 108 4.1 ± 1.3Preterm delivery
Yes 12 9.6 ± 5.8
< 0.001𝑏
No 114 4.5 ± 2.7SGA
Yes 6 6.1 ± 3.3
0.20𝑏
𝑎The ANOVA test was used
𝑏The student t test was utilized
SGA: Small for gestational age; BMI: Body mass index; N: Number; SD: Standard deviation
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Table III. ROC curves for maternal serum CRP levels for predicting preterm delivery and SGA
Variables Surface under area P-value CI 95%
Lower limit Upper limit
Preterm 0.836 < 0.01 0.693 0.980
SGA 0.673 0.15 0.441 0.905
ROC: Receiver operating characteristic; CRP: C-reactive protein; SGA: Small for gestational age; CI: Confidence interval
Table IV. Accuracy parameters of the study
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Preterm delivery (CRP ≥ 5.27 mg/l) 75 86.1 37.5 96.87 85
SGA (CRP ≥ 6.67 mg/l) 50 91.2 23.07 97.19 89.2
Table V. Logistic regression analysis for maternal serum CRP levels and risk of Preterm and SGA birth
B SE Odds P-value 95% CI
Preterm delivery
One-unit increase in CRP levels 0.89 0.29 2.26 < 0.01 1.28–3.99
CRP ≥ 5.27 mg/l 2.93 0.72 18.6 < 0.01 4.51–76.6
SGA
One-unit increase in CRP levels 0.12 0.09 1.13 0.20 0.93–1.34
CRP ≥ 6.67 mg/l 2.34 0.59 10.4 0.01 1.88–58.4
SE: Standard error; CRP: C-reactive protein; CI: Confidence interval
Logistic regression analysis was utilized
4. Discussion
Our findings showed that maternal serum CRP
levels at early gestation are a useful predictor of
preterm delivery. This finding is compatible with
several other studies that measured the maternal
serum CRP levels before 20 wk gestation (1, 8, 12,
16), and those studies measured serum CRP levels
after 20 wk, for example, a study by Grgic and
colleagues (17), at 20-24 wk gestation, and a study
by Shahshahan and colleagues (18), at 24-34 wk of
gestation, which reported a significant increase in
the preterm group compared to the term deliveries
in patients with higher CRP serum levels. However,
this is in contrast to studies reporting no significant
difference in serum CRP levels measured at 15-
18 wk gestation (9, 13, 19) and at 16-27 wk of
gestation published by Bullen and colleagues (20)
between the preterm and term deliveries. Bullen
and colleagues demonstrated that CRP levels
were non-significantly elevated for preterm (5.5
µg/ml) versus term deliveries (4.8 µg/ml) and were
higher in the preterm deliveries with histologic
chorioamnionitis (6.3 µg/ml). They also showed a
significant association between preterm and CRP
only in higher pregestational BMI (> 30) women
(7.5 mg in preterm vs 6.6 mg/ml in term deliveries;
p < 0.05) (20). Moreover, we found that the best
cut-off value of maternal serum CRP levels in
the first trimester was 5.27 mg/l for predicting
the preterm delivery. This cut-off differs between
literature; Grgic and colleagues (17) described a cut-
off of 4 mg/l, Pitiphat and colleagues reported a
CRP serum levels ≥ 8 mg/L (21), and Ertas and
colleagues (22) described a CRP cut-off of 9.66
mg/L with a greater risk of preterm delivery. The
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potential explanations depend on many factors
such as the inclusion and exclusion criteria of
the study populations and mainly a time period
of measurement. The increase in maternal serum
CRP in preterm deliveries reflects an activated
inflammatory pattern as a result of upregulated
secretion of cytokines (15).
As observed through the literature review, there
are some studies showed a significant association
between CRP at early pregnancy and preterm
delivery (1, 8, 12, 16), while others failed to confirm it
(9, 13, 19). Our finding that maternal serum levels
of CRP at 5-20 wk are associated with preterm
delivery suggests that inflammatory process can
be apparent from early pregnancy. We showed
the OR of 1.31 (CI 95%: 0.93–1.34, p = 0.20) in
association between one-unit increase in serum
CRP levels and SGA births, but this increased
dramatically (the OR of 10.4, CI 95%: 1.85–58.47,
p <0.01) in association with CRP levels above
6.67 mg/l with SGA births. Moreover, in our study,
the mean CRP levels did not differ significantly
betweenwomenwith SGA and thosewith non-SGA
births, however, this comparison was significant
when we compared the categories of birth weight;
we reported significantly higher CRP serum levels
at early pregnancy in women with neonate’s birth
weight < 2000 gr.
Previous studies on biomarker of SGA
have assayed blood samples collected
during pregnancy, however, most of these
studies addressed abnormalities in maternal–
fetal interface immune regulation, there are
considerable inconsistencies between them,
which can be attributed to varying time window
for blood collection and racial differences (1, 4,
23-26). In a study by Vecchie and colleagues in
2018, it has been reported that CRP serum levels
at midpregnancy were significantly higher in the
group with maternal adverse outcomes and these
mothers have smaller babies (15).
5. Conclusion
In conclusion, we observed a positive
association between serum CRP levels and
higher rates of preterm deliveries and SGA births.
The novelty of our study was measuring CRP levels
in early pregnancy and also assessing the preterm
deliveries and SGA birth together. Hence, the
current study can add some piece of information
on the existing knowledge in relation between
early CRP levels and preterm deliveries and SGA
birth. However, the number of cases to draw a
firm conclusion from is also insufficient. Moreover,
the range to measure CRP has been too wide
which might reduce the significance of the study
and produce biasness. Another limitation that
needs to be mentioned is that CRP itself is a very
nonspecific marker which in spite of using strict
exclusion criteria can be positive or high for other
reasons that can produce some biasness. Finally,
higher maternal serum CRP levels measured early
in pregnancy may associate with higher risk of
preterm delivery and SGA.
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